Volume 30, 1993 author and keyword index

Brain Research Bulletin. Vol. 30, pp. 119-723, Printed in the USA. All rights reserved.

1993 Copyright

0361-9230/93 $6.00 + .OO 0 1993 Pergamon Press Ltd.

AUTHOR INDEX Aguero, A., 585 Akiyama, K., 107 Aldskogius, H., 395, 447, 499 Al-Ghoul, W. M., 453 Almeida, 0. F. X., 7 Ante], J. P., 197 Apvel. S. H.. 373 Arnedo, M.. 585 Arvidsson, J.. 499 Auclair, F., 273, 28 I Audet, G., 227, 325 Ayer, K., 417 Badache. A., 5 15 Bains, J. S., 33 Barbeau, H., 387 Barber, W. D., I 19 Baron, G., 29 1 Bazan, N. G., 691 Btlanger, M.-C., 273, 28 I Bertrand, L., 273. 415 Bevan, L., 127 Bhatnagar. R., 395 Billiar, R. B., 629 Block, C. H., 677 Borowski, T. B., 607 Bos, N. P. A., 157 Boullerne, A.. 365 Briggs, J., 4 1 Brochet, B., 365 Brown. W. F.. 359 Buijs, R. M., I Burnham. P., 347 Cabana, T., 29 I Calcagnetti, D. J.. 593, 695 Cales, J. M., 649 Calka, J.. 677 Campbell, 1. G., 143 Carbonell-Hernandez, C., 67 Carlstedt, T., 405, 447 Carr, P. A., 209 Cassidi, G., 29 1 Cerne, R.. 329 Chakraborty, G., 439 Chang, H. T., 115 Chau. C., 387 Chen, L-J., 641 Chen, L.-D., 153 Cheng, M.-F., 7 I I Chowdrey, H. S., 535 Compaan, J. C., I Conradi, S., 369 Constantakakis, E., 38 1 Cruz-Morales, S. E., 67 1 Cuello, A. C., 197 Cullheim, S., 405 Curtis, K., 41 Dafny, N., 529 Das. G. D.. 395 Davis, B. J:, 69 De Koninck, Y., I97 Delree, P., 23 I, 507 De Ruiter, A. J. H., 1 Diaz del Guante, M. A., 67 1

Kawahara, N., 353 Kiernan, J. A., 359 Kimura, M.. 701 Kirkby. R. D., 607 Kisilevsky, R.. 46 1 Knighton, D., 353 Knoops. B.. 433 Kobori, M., 53 Kokkinidis, L., 597, 607 Koolhaas, J. M.. I Kost. S. A.. 469 Krukoff. T. L.. 163 Kuchler, S., 5 I5

Dow, K. E., 461 Duncan, R., 423 Ebers, G. C., 359 Elson, A. S., 687 Engelhardt, J. I., 373 Enriquez, P., 649 Eriksson, P.. 499 Faeth, J. A., 85 Fang, T.-Q., 53 Fare]. P. B., 483 Feinberg, I., 143 Ferguson, A. V., 33 Fiegel, V. D., 353 Figlewicz, D. P., 57 I Fontaine-P&us, J., 25 Freemen. R. P.. 687 Fried, K., 405

Laouris, Y .. I27 Larsen. P. J., 535 Lawson. S. N., 239 Lee. C. A., 655 Lee. T. F.. 149 Lefebvre, P. P., 23 I Lehmann, S., 5 I5 Leprince, P.. 23 I. 507 Lewin, G. R., 245 Li Volsi. G.. 453 Li. E. T. S.. 547 Li. Z.. 33 Lightman. S. L., 535 Lin, J.-Y.. 177 Lindi. H.. 405 Liu. F.-Y., 529 Lo, Y.-C.. 64 I Luo. C.-P., 53 Luo. s.. 547

I

Gallo, M., 585 Garland, S. J., 127 Gartner, J. G.. 101 Gaulin, F., 227. 325 Gelfard, M., 227, 365 Gilmore, S., 339 Glassman, R. B.. 189 Glover. J. C., 265 Gobaille, S., 5 I5 Godefroy. F., 3 I9 Gordon. T.. 477 Graham, S. R., 597 Grant. G., 197. 199 Green, P. K., 57 I Greenberg, A. H.. 101 Guillamon, A.. 649 Guo, M.. 461 Gylys, J. A., 687

I

Jessop. D. S., 535 Jhamandas, J. H., 163 Jiang, M. C., 329 Jin, Z. L., 149 Jones, K. J., 49 I Joshi, D., 629

Magal. E.. 347 Maahami. G.. 423 Maihotta, S. K., 395 Manchester. L. C., I53 Mano, T.. 1 I, 181 Marchand, R.. 195. 273. 281, 415 Marlier. L., 6 I7 Marschal, P., 5 15 Martin, D., 23 I, 507 Martin, G. F., 303 Marusich, M. F., 257 Matsukura. T., 107 Mayo-Michelson, L.. 79 McCarthy, P.. 239 Meeker, M. L., 483 Mendell, L. M., 245 Mera, H., 53 Miller. L. G., 69 I Miller, M. M., 629 Mirmiran, M., 157 Mitev. Y.. 7 Mizuno, T.. 53 Molander, C., 499 Montiel. M., 6 I I Moonen, G., 23 I, 507 Morata, P.. 6 I 1 Morell. M., 61 I Munoz, D. G.. 359 Murer, G. M., 635

Kakeyama, M., 705 Kang, I., 69 I

Nagy, J. I., 209 Nakamoto, R. K., 107

Hagg, T., 347 Hallin. R. G., 447 Hammer, Jr., R. P., 523 Haraguchi, M.. 133 Hanington. M. E., 655 Harris, K. H., 163 Havens, M. H.. 7 I 1 Henry, J. L., 197 Hiraizumi, Y.. 353 Hisamitsu, T., 53 Hodge, C. W.. 133 Hubert, I., 433 Hudson, A. J.. 359 Ibata, Y., 551, 561 Ingoglia, N. A., 439 Inoue, C., 4 I Israel, P. A., 57 1

719

Nance, D. M., 101 Nieves, H.. 153 Nilsson-Remahl, I.. 447 Nitsch, C.. 2 1 Oblinger, M. M.. 469 O’Conner, R. C.. I89 Oka. K., 53 Okamura, H.. 551. 561 Oudega. M., 347 Pan, J.-T., 177 Park, C. R., 57 I Patchev. V., 7 Pazo, J. H., 635 Perry, M. J., 239 Persson, J. K. E., 499 Pflieger, J.-F., 29 I Philippe. E., 195, 227, 325 Phillips, N.. 339 Pindzola, R. R.. 303 Plaitakis. A.. 38 I Ponsar, C., 433 Pool, c. w., I Port. R., 4 I Porte, Jr.. D., 57 I Poulat, P., 6 17 Prabhakar. E.. 239 Prado-Alcali. R. A.. 67 I Pratt, J. S.. 69 I Pringle. C. E.. 359 Privat. A.. 617 Puerto. A., 585 Pulido, J. S.. 85 Qiao. J.-T.. 529 Quirarte. G.. 67

I

Rahmani, T., 655 Rajaofetra, N.. 6 I7 Randic. M., 329 Reinking, R. M.. 127 Reiter, R. J., 153 Rende, M.. 347 Ribbens, C., 23 I Ribeiro-Da-Silva. A., 197 Riederer, B. M.. 623 Rigo, J. M., 231. 507 Riopelle. R. J., 46 I Risling. M., 405 Ritter, A. M., 245 Rivas-Arancibia, S., 67 I Rivier. C.. 173 Rogister, B., 23 I, 507 Ronnevi. L.-O., 369 Rossignol, S.. 387 Rusin, K. I., 329 Rustioni, A., 453 Samson, H. H.. 133 Sanchez-Santed, F., 649 Satoh. S.-I.. 701 Schaefer, F., 2 I Schechter. M. D.. 593. 695 Schoenen, J., 231, 507 Schwartz, M. W., 571 Scotti, A. L., 2 1

720

Seatriz. J. V., 513 Segal. E.. 635 Seidler. F. J.. 9 1 Serrano-L~ano, A.. 6 I 1 Seybold, K., 41 Sheridan, R. E., 57 I Shibuya. M.. 701 Shires. T. K.. 85 Shnitka. T. K., 395 Shonis. C. A.. 45 Sims. T. J., 339 Sipols. A. J.. 571 Slotkin. T. A.. 91 Smith. R. G.. 373 Stein. R. B. 477 Stuart. D. G.. 127 Subr. V.. 423 Sugimoto. 7.. 22 I Sugita. K.. 701 Sun. J.-H.. 153

INDEX

Sung. J. H.. 353 Sutoo. D., 107 Suzuki, M.. 1I. 181 Suzuki, I’., 70 I Svensson. M., 3YS. 49Y Swaab. D. F.. 157

Valdes. N., 4 I5 Van Den Bosch De Aguilar, 433 Varon. S., 347 Vincendon. G.. 5 I5 Vriend. C. Y.. IO1

Tajti, J.. 373 Takayasu. M.. 701 Takemura, M.. 231 Takeshige. C., 53 Tanaka,.M.. 561 Tanaka. Y.. 56 1 Tolliver, G. A.. I33 Torres. G.. I73 Transfeldt. E. E.. 353 Tyreman. N.. 477

Waldrop. T. G.. 45 Wan, W., IO1 Wang. L. f. H.. 149 Wang, Y.. 64 I W&l-Fugazza. J.. 3 19 Weinberg. R. J.. 453 Wermore. L.. 101 White. P.. 339 Witting. W.. 157 Woerly, S.. 4 15,423 Wolfrum, G., :! I Woods. S. C.. 57 I Wright. R. N.. 687

Ulhrich. K.. 423 Unger. J.. 7 1

Xu. X. M., 303 I’..

YLl@, K.. 153 Yamanouchi. K.. 705 Yamazaki, Y.. I I, 181 Yanaihara, N.. 561 Yang, J. F.. 477 Yeh. J.-L.. 64 I Yokoyama, f., 55 1 Young, G. A.. 7; Yuan. C.-S.. I19

Zanetta. J.-P.. 5 I5 Zhou. C.. 127.375 Zhou, S. J.. 149

KEYWORD INDEX Acetyichoiine. 149, 597, 67 1 ACTH, 535 Adenosine, 149 Adenosine receptor, 149 Adrenalectomy, 6 I7 Adult rats, 6 1 I Aggression, 1 Aging, 149. 157 ALS. 373 Alzheimer’s disease, 157 Amphetamine, 133, 607 Amygdala, 591 Amyotrophic lateral sclerosis, 359, 369, 38 I Analgesia, 3 19 Angiogenesis, 353 Angio~phy, 70 1 Angiotensin. 677 Angiotensin II, 33, 593 Anterograde axonal transport, I I5 Anterograde tracing, 163 Antiserum of beta-endorphin, 53 Anti-TRITC, I I5 Apomo~hine, 387 Arcuate nucleus. 177 Area postrema, 119, 585 Arterial pressure, 64 1 Arthritic rats, 3 19 Astrocyte, 433, 46 I Astroglia. 499 Auto-antibody, 257 Autoimmune. 373 Autonomic regulation. 163 Autoradiography. 629 Autoshaping, 67 I Aversion learning, 585 Avulsion, 447 Axon pathlinding, 265 Axonal growth, 423 Axonal regeneration, 4 15, 433 Axonal tracing, 199 Axoplasmic transport-acetylcholinestrase, 369 Axotomy. 347. 469. 49 I, 499 Basal lamina, 405 Bed nucleus of the stria terminalis, 1 Behavior, 79 ~~ndo~hin. 7 Blood-brain barrier, 405 Body righting, 29 1 Bombesin, I77 Brachial plexus injury, 447 Brain, 623 Brain development, effects of cocaine, 91 Brain dopamine. 107 Brain growth. 523 Brain regions, 6 I 1 Brain slice, 45, I77 Brain stem. 273. 28 1 Bullfrog, 483 Buproprion, 607 Buspirone, 547 Calbindin D28k. 209 Calcitonin gene-related peptide, 209, 453 Calcium, 107 Calcium channel, 373

Calcium channel blockade, 593 Calmodulin, 107 Canine basilar arterv. 701 Capsaicin, 641 * Carbodiimide, 4 I5 Carbohydrate, 547 Carbonic anhydrase, 209, 22 I Cardiovascular actions, 64 1 Cat. 119. 387 Caudate nucleus, 67 1 Cell adhesion, 423 Cell size analysis, 22 I Central conduction times, 359 Cerebellar lateral nucleus, 529 Cerebellum, 623 Cerebral cortex. 523 C fibers, 453 c-fos, 173 CGRP (calcitonin gene-related peptide), 239 Chick, 227 Chick neurotransmitter, 325 Choline. 67 I Cholinergic neurons, 433 Chondroitin-6-sulfate. 415 Ciliary neurotrophic factor. 347 Cin8ulate bundle (CB), 53 Circadian rhythm(s), 157, 655 Circling behavior, 2 I Circumvetricular organ, I 19 Clonidine, 387 Clozapine. 597 CNS regeneration, 405 Cocaine. 173,695 Cocaine. effects on brain development. 9 I Collagen hydrogel, 4 I5 Collagen matrix. 4 I5 Comparative psychology, I89 Computer, 143 Conditioning, 671 Conduction velocity, 239 Coo-responsive units, 71 1 Cortical, 577 Corticosterone, 7 CPP, 173 CRH. 7 CSF insulin. 57 1 Cyproterone acetate, 649 Cytochrome oxidase, 209 Cytoskeleton. 623 Dl-D2 dopamine receptors, 635 Delta, 143 Dentate nucleus, 529 Descending pathways. 28 f Desipramine, 607 Development, 245,29 1,523 Developmental restrictions, 257 Dextran amines, I 15, 265 Diabetes mellitus, 85 Diabetic retinopathy, 85 Dihydrotestosterone, 649 Dil, 415 Dimethyl sulfoxide, 593 DNA, effects of cocaine, 91 Dopamine, 227, 3 19, 597 Dopaminergic neurons, 55 I

721

Dorsal hip~ampus (D-Hip), 53 Dorsal periaqueductal central gray (D-PAG), 53 Dorsal raphe nucleus, 705 Dorsal root, 447 Dorsal root ganglia, 209, 227, 239 Dorsal root ganglion, 23 I Drinking, 593 Early postnatal sex steroids, 649 EEG power spectra, 79 Electrical stimulation, 585 Electroconvulsive shock, 69 1 Electromagnetic field, I53 Electromyogram, 1I Ei~tromyography (EMG). 447 Electrophoresis, 365 Electrophysiology, 33 Endogenous lectins, 5 I5 Endorphins, 523 Entopeduncular nucleus. 635 Estradiol, 649 Estrogen, 629 Ethanol, 133 Evoked potential, 53 Excitatory amino acids, 329. 38 I, 453 Extinction, 649, 695 Extracellular recording, 45 Facial nerve, 49 1 Fatigue, 127 Fischer 344 inbred rat strain, 79 5-HT, 56 I 5-HTIA agonist, 547 5-HT,_, receator. 687 5-HT,, recebtor. 687 5-HTz receptor, 687 Fluid balance. 677 ~uo~de-resistant acid phosphata~, 209 Fluoro-Ruby, 115 Food deprivation, 7 Force recovery. I27 GABA, 69, 325,607 GABAa receptor, 691 Gastric releasing peptide, 655 Gastric vagal branches, 119 Gel electrophoresis, 85 Genesis of circuits, 273 Gerbil, 29 I Glycoproteins, 5 I5 Gonadal steroid, 49 I Guinea pig, 687 Gut backgraft, 25 1 Habenulo-interpeduncular tract (HP), 53 Haloperidol, 597 Hamster, 69, 655 HCN-IA, 577 Hippocampus, 41, 149,433, 597 Histogram of neuronal activity, 53 Hodogenesis, 273 Homeobox genes, 265 Hopping, 291 Human, I I, 181,577 Humoral immunity, 10 I

122

INDEX

Hydrogels, 423 Hyperalgesia, 245 Hypertension. 45 Hypoglossal nerve axotomy. 395 Hypophysectomy, 53 Hypothalamic paraventricular nucleus, 33 Hypothalamo-pituitary-adrenal axis, 535 Hypothalamus. 303, 535, 551, 629, 677 Hypothyroidism, 6II lbotenic acid, 2 1 Image analysis, 6 I7 Immune complex, 365 Immunocvtochemistrv. 227. 239. 395. 55 ImmunoGobulin. 373 Immunohistochemistry, 535 Immunostaining. 365 Immunosuppression. 101 In situ hybridization, 469 In situ hybridization histochemistry. 535 Inhibitory system, 705 Injury, 405 Insulin, 57 1 Insulin transport, 57 1 Intermediolateral cell column. 6 I7 Interstitial nucleus of Cajal, 28 1 Intracellular recordings, 239 Intracisternal injection. 701 Intraperitoneal, 547 lntraspinal implantation, 447 lntraspinal Schwann cells. 339 lntrathecal injection. 64 1 Intraventricular. 593 Isradipine. 593 Ketamine Kindling.

mixture, 597

173

Lacerated spinal cord, 395 Lateral hypothalamus (LH). 53, 303 Lateral parabrachial nucleus, 585 Lateral septum (L-Sep), I, 53 Lateral vestibular nucleus, 28 I Learning, 43, 67 I Lesion. 585 Lewis inbred rat strain 79 Light, 143 Light therapy, 157 Locomotion, 387 Locus coeruleus, 303 Long-term potentiation of primary afferent transmission, 329 Lordosis behavior, 705 Losartan (Dup-753). 33 Lower motor neurons, 359 Mab 51-31, 395 Magnetic resonance imaging. 359 Male rat, 705 Marker, 257 MEAGL, 561 Melatonin, I53 Memory, 189 Mesolimbic DA. 133 Microglia, 499 Microinjection, I33 Microphotometry system, 107 Microtubules, 469 Midbrain, 7 I I Mitogens, IO 1 MK 801. 173

I. 6 I7

Monoclonal antibody, 257 Monopolar EMG, 18 1 Morphine, 79, 3 19. 523 Morphology, 69 Motoneuron(s). 3 19. 325. 347. 405. 499 Motoneurone, 373 Motor axons, 483 Motor cortex, 469 Motor evoked potentials. 359 Motor neuron. 347. 369 Motor unit size. 477 Motor units. 127 Movement artifact. I8 I mRNA. 469,69 I MTT test. 423 Mu-opiod receptors, 629 Multiule sclerosis. 365 Muscie beneath acupuncture point. 53 Myelin basic protein, 365 Myoclonus, 687 N-Acetyltransferase, I53 NADPH-diaphorase. 677 Naltrexone, 523 Neonatal rat. 55 I Neostriatum, 107 Nerve growth factor. 245. 347 Nerve growth factor receptor. 347 Nerve regeneration. 439 Neural crest. 257 Neural crest migration, 25 I Neural plasticity. 469 Neural regeneration, 469 Neural tissue biocompatibility. 423 Neural transplantation. 507 Neurite growth. 46 I Neuritogenesis, 23 I Neurotilament(s). 239, 623 Neurogenesis. 257. 273 Neuromuscular system. 325 Neuronal. 623 Neuronal packing density. 523 Neuronal pattern, 273 Neuronal recognition. 5 15 Neuronal response to noxious stimulation. Neurons, 577 Neuropathy, 257 Neuropeptide Y. 2 I Neurosecretion. 677 Neurotensin. 177 Neurotransmitter(s), 227. 23 I Neurotrophic factor, 405 Nigro-thalamo-cortical loop, 2 I NMDA. 607 Nociception. 245, 3 I9 Nociceptive responses, 529 Norepinephrine. 101. 319, 387 Normosensitive model, 635 NREM, 143 W-terminal arginylation. 439 Nucleus accumbens, 107. 133 Nucleus of the solitary tract, 69 Nucleus tractus solitari. 641 Nucleus tractus solitarius, I 19 Nutritional status. 547 Obesity, 57 I Okadaic acid. 70 I Ontogenesis, 28 1 Opiate receptor, 523 Opioids, 523

Optic nerve. 439

Ornithine

decarboxylase.

effects

ofcocaine,9 I

Pain control systems. 3 I9 Parafascicular neurons, 529 Parasympathetic. I 19 Paraventricular. 677 Paraventricular nucleus. 303 Partial denervation. 477 Parvalbumin. 209, 325 Passive transfer. 373 Pavlovian conditioning. 695 PBN. 163 Peptide histidine isoleucine. 655 Peripheral nerve injury. 347 Peripheral nerves, 453 Peripheral projections. 227 PHA-L. 163 Phosphorylation, 623 Picrotoxin, 607 Pilocarpine. 597 Pineal gland. 153 Place oreference conditionina. 695 Placing, 29 I Plasticity, 43. 33 I Platelet-derived wound-healing formula. 353 Positron emission tomography. 359 Posterior hypothalamus. 45 Primary lateral sclerosis, 359 Primary neuron. 22 I Primary sensory neuron(s). 199. 209 Propriospinal neurons. 303 Proprotachykinin A mRNA. 535 Protein. 547 Protein pattern. 365 Proteoglycans. 46 I Proteolysis. 439 Proximal and distal reactive astrocytes. 395 Pyramidal cells. 359 Quail chick chimeras, 25 I Quantitative immunohistochemistry,

53

107

Raclopride. 133 Raphe nuclei. 303 Rapid movement, II Rat(s), 21. 45. 133. 143, 153. 157. 163, 173. 239. 245. 339. 433, 507. 529. 535. 585. 617. 695 Rat brain stem. 56 I Red nucleus, 303 Regeneration, 347, 447. 46 I. 49 I Reinforcement 695 Repair, 5 I5 Reticular formation, 28 1, 303 Reticulospinal. 265 Reward, 695 Rhombomere. 265 Ring dove. 7 I I Rooting, 29 I Salt loading. 535 Saxitoxin, 577 Scanning electron microscopy. 423 Scar formation. 415 Scar remodelling. 4 I5 Scar tissue, 405 Schwann cell, 433, 507 Sciatic nerve. 347. 439 Segmental determination, 265 Self-administration. 133

INDEX

Sensitization, 607 Sensorimotor reflexes, 29 1 Sensory ganglion, 499 Sensory neuron(s), 227, 245, 447 Sensory neurones, 239 Septum, 433 Serotonin, 6 I7 Serotonin neuron, 705 Serotonine, 3 19 Sex difference, 649 Short-term memory capacity, 189 SHR, 45 Single-unit recording, 177 6_hydroxydopamine, 2 I, 55 1 Skeletal muscle. 325 Sleep, 143 Sleepwakefulness, 157 Sodium channels, 577 Soluble vitreous proteins, 85 Somatosensory neurotransmitters, 453 Somatostatin, 209, 239 Spatial memory, I89 Spinal cord, 199, 3 19, 325, 339, 347, 387, 405 Spinal cord growth, 25 I Spinal cord injury, 353,477, 507 Spinal cord tissue, 38 I Spinal dorsal horn neuron, 329 Spinal lesion, 4 I5 Spinal nerve root, 447

123

Spinalization, 387 Splenic denervation, 101 Spontaneous hypertensive rat, 45 Spontaneously hypertensive rats, 107 Sprouting, 477 Stress, IO1 Striatum, 21, 671 Structural organization, 199 Subcutaneous, 547 Subfornical organ, 33 Substance P, 209, 239, 453. 535 Substance P antagonist, 64 I Substantia gelatinosa, 209 Substantia nigra, 2 1 Substrate pathways, 273 Suprachiasmatic nucleus, 655 Supraoptic, 677 Sympathetic preganglionic neurons, 6 17 Sympathetics, 101 Synaptogenesis, 5 15 Syngeneic transplantation. 507 Tachykinins, 329 Tamoxifen, 649 Taste, 69 Testosterone, I, 49 1 Tetramethylrhodamine, 1 I5 Tetrodotoxin, 577 Thyrotropin-releasing hormone, 6 17

Tooth pulp, 22 1 Transfer RNA, 439 Transforming growth factor a, 23 1 Transganglionic, I99 Transplants, 483 Tubulin, 469 Turning behavior, 635 Type II S-deiodinase, 6 11 Ubiquitination, 439 Vagus reflex, 64 1 Vasopressin, 1 Ventral rhizotomy, 483 Ventral root, 447 Vestibular nuclei, 303 Vestibulo-ocular, 265 Vestibulospinal, 265 Vitreous protein isolation, 85 Whole-cell voltage-clamp, 329 WRY, 45 Working memory, 189 X-radiation, 339 Zimelidine, 607